The effect of Montelukast in reducing disease recurrence in patients with ulcerative colitis - Trial IRCT20121212011738N3
Access comprehensive clinical trial information for IRCT20121212011738N3 through Pure Global AI's free database. This Phase 3 trial is sponsored by Tabriz University of Medical Sciences and is currently Completed. The study focuses on Ulcerative colitis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20121212011738N3
Phase 3
Completed
drug
Trial Details
Iranian Registry Of Clinical Trial • IRCT20121212011738N3
The effect of Montelukast in reducing disease recurrence in patients with ulcerative colitis
Determining the effect of Montelukast in reducing disease recurrence in patients with moderate to severe ulcerative colitis during the period of gradual reduction of glucocorticoid dose.
Study Focus
Sponsor & Location
Tabriz University of Medical Sciences
Iran
Timeline & Enrollment
Phase 3
Oct 12, 2022
N/A
ICD-10 Classifications
Ulcerative colitis
Other ulcerative colitis
Ulcerative colitis, unspecified
Arthropathy in ulcerative colitis
Juvenile arthritis in ulcerative colitis
Data Source
Iranian Registry Of Clinical Trial
IRCT20121212011738N3
Non-Device Trial